Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

A New Era in Myeloma: An Interview with Elena Zamagni

In the beginning, when I was very young, I was more interested in acute leukaemia and the suffering of young people. When I got to…

New Therapeutic Targets Identified in Childhood Acute Myeloid Leukaemia

A recent study has revealed promising targets for treating childhood acute myeloid leukaemia….

Onima Chowdhury and Kevin Rouault-Pierre

Hema Now: Episode 20: The Science Behind Myelodysplastic Syndromes

Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes (MDS), and their implications for future care.

Congress Wrap: EHA 2025

Our wrap-up video captures all the key moments from the European Hematology Association (EHA) Congress 2025, watch now

Key Enzyme Driving Aggressive Leukaemia Growth

Researchers have uncovered a crucial enzyme responsible for a specific chemical modification linked to the growth of a severe subtype of acute myeloid leukemia…

Novel Therapy Tested to Prevent Chemotherapy-Related Heart Damage

A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at preventing heart damage caused by…

From Bench to Bedside and Back: An Interview with Joshua Richter

Joshua Richter – Associate Professor, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. What initially…

Longer Duration of Obesity Linked to Poorer Survival in Children with Leukaemia

Children with ALL who are overweight or obese at multiple points during treatment have worse survival rates and higher relapse risk, according to a cohort study of 794 patients.

Loading posts...

« Previous 1 … 14 15 16 17 18 … 100 Next »